Importantly, these studies demonstrate a consistent pattern: whilst retained gastric contents are significantly more common in GLP-1 RA users, the absolute rates vary considerably depending on patient factors, medication duration, and assessment methods [35]
it is not a direct substitute for a balanced diet, clinical dermatological treatments, or a healthy lifestyle, nor is it intended to diagnose, treat, cure, or prevent any chronic health issue or medical condition
197 reported increased total cysteine availability in the serum of women with ovarian tumours, regardless of whether the tumours were benign or malignant
52 Acknowledging the limitations of the design while referencing the pivotal trial, the Pediatric Endocrine Society stated, [] the severe phenotype of untreated adults, the significant increase in (near-) adult height reported, the unanimous growth velocity acceleration compared to pre-treatment values in multiple short-term studies, and the lack of an alternative treatment make IGF-1 a strongly recommended treatment for growth failure in patients with primary insulin-like growth factor-1 deficiency []. 14 Health-Related Quality of Life As HRQoL was not reported in any of the studies included in the current review (it was investigated in the EU-IGFD Registry, but data were only available for 2 patients at baseline and some time point thereafter), the impact of mecasermin on HRQoL is unknown
.webp)
